6838 — Formosa Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Formosa Pharmaceuticals, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	41.9	209	421	1,216	1,646
Net Total Receivables	—	0.021	0.033	33.2	40.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	54.5	234	456	1,288	1,728
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14.1	8.19	10.2	34.4	29.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	462	689	878	1,727	2,112
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45.9	19.3	69.6	258	198
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	262	296	411	587	564
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	199	393	467	1,140	1,548
Total Liabilities & Shareholders' Equity	462	689	878	1,727	2,112
Total Common Shares Outstanding